Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 35.452
1.
Alzheimers Res Ther ; 16(1): 108, 2024 May 14.
Article En | MEDLINE | ID: mdl-38745197

BACKGROUND: Sporadic cerebral amyloid angiopathy (sCAA) is a disease characterised by the progressive deposition of the amyloid beta (Aß) in the cerebral vasculature, capable of causing a variety of symptoms, from (mild) cognitive impairment, to micro- and major haemorrhagic lesions. Modern diagnosis of sCAA relies on radiological detection of late-stage hallmarks of disease, complicating early diagnosis and potential interventions in disease progression. Our goal in this study was to identify and validate novel biomarkers for sCAA. METHODS: We performed a proximity extension assay (PEA) on cerebrospinal fluid (CSF) samples of sCAA/control participants (n = 34/51). Additionally, we attempted to validate the top candidate biomarker in CSF and serum samples (n = 38/26) in a largely overlapping validation cohort, through analysis with a targeted immunoassay. RESULTS: Thirteen proteins were differentially expressed through PEA, with top candidate NFL significantly increased in CSF of sCAA patients (p < 0.0001). Validation analyses using immunoassays revealed increased CSF and serum NFL levels in sCAA patients (both p < 0.0001) with good discrimination between sCAA and controls (AUC: 0.85; AUC: 0.79 respectively). Additionally, the CSF: serum NFL ratio was significantly elevated in sCAA (p = 0.002). DISCUSSION: Large-scale targeted proteomics screening of CSF of sCAA patients and controls identified thirteen biomarker candidates for sCAA. Orthogonal validation of NFL identified NFL in CSF and serum as biomarker, capable of differentiating between sCAA patients and controls.


Biomarkers , Cerebral Amyloid Angiopathy , Neurofilament Proteins , Humans , Female , Biomarkers/cerebrospinal fluid , Biomarkers/blood , Cerebral Amyloid Angiopathy/cerebrospinal fluid , Cerebral Amyloid Angiopathy/diagnosis , Male , Neurofilament Proteins/cerebrospinal fluid , Neurofilament Proteins/blood , Aged , Middle Aged , Immunoassay/methods
2.
Methods Mol Biol ; 2808: 225-246, 2024.
Article En | MEDLINE | ID: mdl-38743374

There is increasing interest in evaluating antibody responses to multiple antigen targets in a single assay. Immunity to measles and rubella are often evaluated together because immunity is provided through combined vaccines and because routine immunization efforts and surveillance for measles and rubella pathogens are combined in many countries. The multiplex bead assay (MBA) also known as the multiplex immunoassay (MIA) described here combines the measurement of measles- and rubella-specific IgG antibodies in serum quantitatively according to international serum standards and has been successfully utilized in integrated serological surveillance.


Antibodies, Viral , Immunoglobulin G , Measles , Rubella , Rubella/immunology , Rubella/epidemiology , Rubella/diagnosis , Rubella/blood , Measles/immunology , Measles/epidemiology , Measles/blood , Measles/diagnosis , Humans , Antibodies, Viral/blood , Antibodies, Viral/immunology , Immunoglobulin G/blood , Immunoglobulin G/immunology , Immunoassay/methods , Rubella virus/immunology , Measles virus/immunology , Serologic Tests/methods
3.
Mikrochim Acta ; 191(6): 330, 2024 05 14.
Article En | MEDLINE | ID: mdl-38744738

In view of a large number of people infected with Helicobacter pylori (H. pylori) with great harm followed, there is an urgent need to develop a non-invasive, easy-to-operate, and rapid detection method, and to identify effective sterilization strategies. In this study, highly specific nanoprobes with nanozyme activity, Ag@Pt nanoparticles (NPs) with the antibody, were utilized as a novel lateral flow immunoassay (LFIA). The optical label (Ag@Pt NPs) was enhanced by the introduction of the chromogenic substrate 3,3',5,5'-tetramethylbenzidine (TMB) and compared with a gold nanoparticles (Au NPs) optical label. Under the optimal condition, Ag@Pt-LFIA and TMB-enhanced Ag@Pt-LFIA for H. pylori were successfully established, two of which were over twofold and 100-fold more sensitive than conventional visual Au NP-based LFIA, respectively. Furthermore, Ag@Pt NPs with the antibody irradiated with NIR laser (808 nm) at a power intensity of 550 mW/cm2 for 5 min exhibited a remarkable antibacterial effect. The nanoprobes could close to bacteria through effective interactions between antibodies and bacteria, thereby benefiting photothermal sterilization. Overall, Ag@Pt NPs provide promising applications in pathogen detection and therapeutic applications.


Alloys , Helicobacter pylori , Metal Nanoparticles , Platinum , Silver , Helicobacter pylori/radiation effects , Helicobacter pylori/drug effects , Silver/chemistry , Metal Nanoparticles/chemistry , Platinum/chemistry , Alloys/chemistry , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Immunoassay/methods , Benzidines/chemistry , Gold/chemistry , Humans , Sterilization/methods , Limit of Detection
4.
J Nanobiotechnology ; 22(1): 239, 2024 May 12.
Article En | MEDLINE | ID: mdl-38735951

Widespread distribution of porcine epidemic diarrhea virus (PEDV) has led to catastrophic losses to the global pig farming industry. As a result, there is an urgent need for rapid, sensitive and accurate tests for PEDV to enable timely and effective interventions. In the present study, we develop and validate a floating gate carbon nanotubes field-effect transistor (FG CNT-FET)-based portable immunosensor for rapid identification of PEDV in a sensitive and accurate manner. To improve the affinity, a unique PEDV spike protein-specific monoclonal antibody is prepared by purification, and subsequently modified on FG CNT-FET sensor to recognize PEDV. The developed FET biosensor enables highly sensitive detection (LoD: 8.1 fg/mL and 100.14 TCID50/mL for recombinant spike proteins and PEDV, respectively), as well as satisfactory specificity. Notably, an integrated portable platform consisting of a pluggable FG CNT-FET chip and a portable device can discriminate PEDV positive from negative samples and even identify PEDV and porcine deltacoronavirus within 1 min with 100% accuracy. The portable sensing platform offers the capability to quickly, sensitively and accurately identify PEDV, which further points to a possibility of point of care (POC) applications of large-scale surveillance in pig breeding facilities.


Biosensing Techniques , Nanotubes, Carbon , Porcine epidemic diarrhea virus , Porcine epidemic diarrhea virus/isolation & purification , Animals , Swine , Biosensing Techniques/methods , Biosensing Techniques/instrumentation , Nanotubes, Carbon/chemistry , Limit of Detection , Immunoassay/methods , Immunoassay/instrumentation , Antibodies, Monoclonal/immunology , Transistors, Electronic , Swine Diseases/diagnosis , Swine Diseases/virology , Spike Glycoprotein, Coronavirus/immunology , Spike Glycoprotein, Coronavirus/analysis , Coronavirus Infections/diagnosis , Coronavirus Infections/veterinary , Coronavirus Infections/virology , Antibodies, Viral/immunology , Equipment Design
5.
Nat Commun ; 15(1): 4035, 2024 May 13.
Article En | MEDLINE | ID: mdl-38740742

Rapid and accurate detection of respiratory virus aerosols is highlighted for virus surveillance and infection control. Here, we report a wireless immunoassay technology for fast (within 10 min), on-site (wireless and battery-free), and sensitive (limit of detection down to fg/L) detection of virus antigens in aerosols. The wireless immunoassay leverages the immuno-responsive hydrogel-modulated radio frequency resonant sensor to capture and amplify the recognition of virus antigen, and flexible readout network to transduce the immuno bindings into electrical signals. The wireless immunoassay achieves simultaneous detection of respiratory viruses such as severe acute respiratory syndrome coronavirus 2, influenza A H1N1 virus, and respiratory syncytial virus for community infection surveillance. Direct detection of unpretreated clinical samples further demonstrates high accuracy for diagnosis of respiratory virus infection. This work provides a sensitive and accurate immunoassay technology for on-site virus detection and disease diagnosis compatible with wearable integration.


Hydrogels , Influenza A Virus, H1N1 Subtype , SARS-CoV-2 , Wireless Technology , Immunoassay/methods , Immunoassay/instrumentation , Humans , Hydrogels/chemistry , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , Wireless Technology/instrumentation , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H1N1 Subtype/isolation & purification , Aerosols , COVID-19/diagnosis , COVID-19/virology , COVID-19/immunology , Antigens, Viral/immunology , Antigens, Viral/analysis , Respiratory Syncytial Viruses/immunology , Respiratory Syncytial Viruses/isolation & purification , Limit of Detection
6.
PLoS Negl Trop Dis ; 18(5): e0011637, 2024 May.
Article En | MEDLINE | ID: mdl-38713648

BACKGROUND: Diagnosis of visceral leishmaniasis (VL) in resource-limited endemic regions is currently based on serological testing with rK39 immunochromatographic tests (ICTs). However, rK39 ICT frequently has suboptimal diagnostic accuracy. Furthermore, treatment monitoring and detection of VL relapses is reliant on insensitive and highly invasive tissue aspirate microscopy. Miniature direct-on-blood PCR nucleic acid lateral flow immunoassay (mini-dbPCR-NALFIA) is an innovative and user-friendly molecular tool which does not require DNA extraction and uses a lateral flow strip for result read-out. This assay could be an interesting candidate for more reliable VL diagnosis and safer test of cure at the point of care. METHODOLOGY/PRINCIPLE FINDINGS: The performance of mini-dbPCR-NALFIA for diagnosis of VL in blood was assessed in a laboratory evaluation and compared with the accuracy of rK39 ICTs Kalazar Detect in Spain and IT LEISH in East Africa. Limit of detection of mini-dbPCR-NALFIA was 650 and 500 parasites per mL of blood for Leishmania donovani and Leishmania infantum, respectively. In 146 blood samples from VL-suspected patients from Spain, mini-dbPCR-NALFIA had a sensitivity of 95.8% and specificity 97.2%, while Kalazar Detect had a sensitivity of 71.2% and specificity of 94.5%, compared to a nested PCR reference. For a sample set from 58 VL patients, 10 malaria patients and 68 healthy controls from Ethiopia and Kenya, mini-dbPCR-NALFIA had a pooled sensitivity of 87.9% and pooled specificity of 100% using quantitative PCR as reference standard. IT LEISH sensitivity and specificity in the East African samples were 87.9% and 97.4%, respectively. CONCLUSIONS/SIGNIFICANCE: Mini-dbPCR-NALFIA is a promising tool for simplified molecular diagnosis of VL and follow-up of treated patients in blood samples. Future studies should evaluate its use in endemic, resource-limited settings, where mini-dbPCR-NALFIA may provide an accurate and versatile alternative to rK39 ICTs and aspirate microscopy.


Leishmania donovani , Leishmaniasis, Visceral , Sensitivity and Specificity , Leishmaniasis, Visceral/diagnosis , Leishmaniasis, Visceral/parasitology , Humans , Leishmania donovani/genetics , Leishmania donovani/isolation & purification , Immunoassay/methods , Leishmania infantum/genetics , Leishmania infantum/isolation & purification , Polymerase Chain Reaction/methods , Spain , Molecular Diagnostic Techniques/methods , Female , Male , Adult , Adolescent , Child , Young Adult , Middle Aged , Africa, Eastern , DNA, Protozoan/genetics , DNA, Protozoan/blood , Child, Preschool
7.
Sci Rep ; 14(1): 10450, 2024 05 07.
Article En | MEDLINE | ID: mdl-38714678

We present an advanced electrochemical immunosensor designed to detect the vascular endothelial growth factor (VEGF) precisely. The sensor is constructed on a modified porous gold electrode through a fabrication process involving the deposition of silver and gold on an FTO substrate. Employing thermal annealing and a de-alloying process, the silver is eliminated from the electrode, producing a reproducible porous gold substrate. Utilizing a well-defined protocol, we immobilize the heavy-chain (VHH) antibody against VEGF on the gold substrate, facilitating VEGF detection through various electrochemical methods. Remarkably, this immunosensor performs well, featuring an impressive detection limit of 0.05 pg/mL and an extensive linear range from 0.1 pg/mL to 0.1 µg/mL. This emphasizes it's to measure biomarkers across a wide concentration spectrum precisely. The robust fabrication methodology in this research underscores its potential for widespread application, offering enhanced precision, reproducibility, and remarkable detection capabilities for the developed immunosensor.


Biomarkers, Tumor , Biosensing Techniques , Gold , Vascular Endothelial Growth Factor A , Gold/chemistry , Humans , Biomarkers, Tumor/analysis , Vascular Endothelial Growth Factor A/analysis , Biosensing Techniques/methods , Immunoassay/methods , Metal Nanoparticles/chemistry , Nanostructures/chemistry , Electrochemical Techniques/methods , Limit of Detection , Early Detection of Cancer/methods , Reproducibility of Results , Neoplasms/diagnosis
8.
Mikrochim Acta ; 191(6): 311, 2024 05 08.
Article En | MEDLINE | ID: mdl-38717575

Urine retinol-binding protein 4 (RBP4) has recently been reported as a novel earlier biomarker of chronic kidney disease (CKD) which is a global public health problem with high morbidity and mortality. Accurate and rapid detection of urine RBP4 is essential for early monitor of impaired kidney function and prevention of CKD progression. In the present study, we developed a time-resolved fluorescence immunochromatographic test strip (TRFIS) for the quantitative and rapid detection of urine RBP4. This TRFIS possessed excellent linearity ranging from 0.024 to 12.50 ng/mL for the detection of urine RBP4, and displayed a good linearity (Y = 239,581 × X + 617,238, R2 = 0.9902), with the lowest visual detection limit of 0.049 ng/mL. This TRFIS allows for quantitative detection of urine RBP4 within 15 min and shows high specificity. The intra-batch coefficient of variation (CV) and the inter-batch CV were both < 8%, respectively. Additionally, this TRFIS was applied to detect RBP4 in the urine samples from healthy donors and patients with CKD, and the results of TRFIS could efficiently discern the patients with CKD from the healthy donors. The developed TRFIS has the characteristics of high sensitivity, high accuracy, and a wide linear range, and is suitable for rapid and quantitative determination of urine RBP4.


Chromatography, Affinity , Renal Insufficiency, Chronic , Retinol-Binding Proteins, Plasma , Humans , Retinol-Binding Proteins, Plasma/urine , Chromatography, Affinity/methods , Renal Insufficiency, Chronic/urine , Renal Insufficiency, Chronic/diagnosis , Limit of Detection , Reagent Strips , Biomarkers/urine , Immunoassay/methods
9.
BMC Vet Res ; 20(1): 169, 2024 May 02.
Article En | MEDLINE | ID: mdl-38698383

BACKGROUND: Bovine mastitis is one of the most widespread diseases affecting cattle, leading to significant losses for the dairy industry. Currently, the so-called gold standard in mastitis diagnosis involves determining the somatic cell count (SCC). Apart from a number of advantages, this method has one serious flaw: It does not identify the etiological factor causing a particular infection, making it impossible to introduce targeted antimicrobial therapy. This can contribute to multidrug-resistance in bacterial species. The diagnostic market lacks a test that has the advantages of SCC and also recognizes the species of pathogen causing the inflammation. Therefore, the aim of our study was to develop a lateral flow immunoassay (LFIA) based on elongation factor Tu for identifying most prevalent Gram-positive cocci responsible for causing mastitis including Streptococcus uberis, Streptococcus agalactiae and Staphylococcus aureus. RESULTS: As a result, we showed that the assay for S. uberis detection demonstrated a specificity of 89.02%, a sensitivity of 43.59%, and an accuracy of 80.3%. In turn, the second variant - assay for Gram-positive cocci reached a specificity of 95.59%, a sensitivity of 43.28%, and an accuracy of 78.33%. CONCLUSIONS: Our study shows that EF-Tu is a promising target for LFIA and we have delivered evidence that further evaluation could improve test parameters and fill the gap in the mastitis diagnostics market.


Mastitis, Bovine , Streptococcus agalactiae , Streptococcus , Mastitis, Bovine/diagnosis , Mastitis, Bovine/microbiology , Animals , Cattle , Female , Streptococcus agalactiae/isolation & purification , Streptococcus/isolation & purification , Staphylococcus aureus/isolation & purification , Sensitivity and Specificity , Streptococcal Infections/veterinary , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiology , Gram-Positive Cocci/isolation & purification , Immunoassay/veterinary , Immunoassay/methods , Staphylococcal Infections/veterinary , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology , Milk/microbiology , Milk/cytology
10.
Anal Chem ; 96(19): 7353-7359, 2024 May 14.
Article En | MEDLINE | ID: mdl-38690857

Accurate detection of multiple cardiovascular biomarkers is crucial for the timely screening of acute coronary syndrome (ACS) and differential diagnosis from acute aortic syndrome (AAS). Herein, an antibody microarray-based metal-enhanced fluorescence assay (AMMEFA) has been developed to quantitatively detect 7 cardiovascular biomarkers through the formation of a sandwich immunoassay on the poly(glycidyl methacrylate-co-2-hydroxyethyl methacrylate)-decorated GNR-modified slide (GNR@P(GMA-HEMA) slide). The AMMEFA exhibits high specificity and sensitivity, the linear ranges span 5 orders of magnitude, and the limits of detection (LODs) of cardiac troponin I (cTnI), heart-type fatty acid binding protein (H-FABP), C-reactive protein (CRP), copeptin, myoglobin, D-Dimer, and N-terminal pro-brain natriuretic peptide (NT-proBNP) reach 0.07, 0.2, 65.7, 0.6, 0.2, 8.3, and 0.3 pg mL-1, respectively. To demonstrate its practicability, the AMMEFA has been applied to quantitatively analyze 7 cardiovascular biomarkers in 140 clinical plasma samples. In addition, the expression levels of cardiovascular biomarkers were analyzed by the least absolute shrinkage and selector operator (LASSO) regression, and the area under receiver operator characteristic curves (AUCs) of healthy donors (HDs), ACS patients, and AAS patients are 0.99, 0.98, and 0.97, respectively.


Biomarkers , Humans , Biomarkers/blood , Biomarkers/analysis , Protein Array Analysis/methods , Limit of Detection , Immunoassay/methods , Fluorescence
11.
Anal Chem ; 96(19): 7367-7372, 2024 May 14.
Article En | MEDLINE | ID: mdl-38696818

Immunogold, that is, gold nanoparticles (AuNPs) conjugated with biomolecules such as antibodies and peptides, have been widely used to construct sandwiched immunosensors for biodetection. Two main challenges in these immunoassays are difficulties in finding and validating a suitable antibody, and the nonspecific interaction between the substrate and immunogold, which lowers the detection sensitivity and even causes false results. To avoid these issues, we took advantage of the nonspecific interaction between AuNPs and capture antibodies and proposed a new sensing mechanism. That is, after the capture of analyte targets by the capture antibodies on the substrate, AuNPs of certain chemical functionality would preferably bind to the free capture antibodies. Consequently, the amount of deposited AuNPs will inversely depend on the concentration of the analytes. As a proof-of-concept, we designed a mass-based sensor where anti-IgG antibodies were coated on a quartz crystal microbalance substrate. After IgG was introduced, tannic acid-capped AuNPs were applied to bind with the free anti-IgG antibody molecules. A frequency change (Δf) of the quartz substrate was induced by the increased mass loading. To further amplify the loading mass, an Ag enhancer solution was added, and Ag growth was catalyzed by the bound AuNPs. The Δf response showed a concentration-dependent decrease when increasing IgG concentration with a detection limit of 2.6 ng/mL. This method relies on the nonspecific interaction between AuNPs and anti-IgG antibodies to realize sensitive detection of IgG and eliminates the use of detection antibodies. The concept is an alternative to many existing immunoassay technologies.


Biosensing Techniques , Gold , Metal Nanoparticles , Gold/chemistry , Metal Nanoparticles/chemistry , Immunoassay/methods , Biosensing Techniques/methods , Immunoglobulin G/immunology , Immunoglobulin G/analysis , Quartz Crystal Microbalance Techniques
12.
Anal Chem ; 96(19): 7643-7650, 2024 May 14.
Article En | MEDLINE | ID: mdl-38708712

Chemiluminescence (CL), especially commercialized CL immunoassay (CLIA), is normally performed within the eye-visible region of the spectrum by exploiting the electronic-transition-related emission of the molecule luminophore. Herein, dual-stabilizers-capped CdTe nanocrystals (NCs) is employed as a model of nanoparticulated luminophore to finely tune the CL color with superior color purity. Initialized by oxidizing the CdTe NCs with potassium periodate (KIO4), intermediates of the reactive oxygen species (ROS) tend to charge CdTe NCs in both series-connection and parallel-connection routes and dominate the charge-transfer CL of CdTe NCs. The CdTe NCs/KIO4 system can exhibit color-tunable CL with the maximum emission wavelength shifted from 694 nm to 801 nm, and the red-shift span is over 100 nm. Both PL and CL of each of the CdTe NCs are bandgap-engineered; the change in the NCs surface state via CL reaction enables CL of each of the CdTe NCs to be red-shifted for ∼20 nm to PL, while the change in the NCs surface state via labeling CdTe NCs to secondary-antibody (Ab2) enables CL of the CdTe NCs-Ab2 conjugates to be red-shifted for another ∼20 nm to bare CdTe NCs. The CL of CdTe753-Ab2/KIO4 is ∼791 nm, which can perform near-infrared CL immunoassay and semi-automatically determined procalcitonin (PCT) on commercialized in vitro diagnosis (IVD) instruments.


Cadmium Compounds , Luminescent Measurements , Nanoparticles , Tellurium , Tellurium/chemistry , Immunoassay/methods , Cadmium Compounds/chemistry , Nanoparticles/chemistry , Color , Luminescence , Automation , Humans
13.
Anal Chim Acta ; 1303: 342520, 2024 May 15.
Article En | MEDLINE | ID: mdl-38609255

BACKGROUND: Cluster of Differentiation 44 (CD44) is considered an important biomarker for various cancers, and achieving highly sensitive detection of CD44 is crucial, which plays a significant role in tumor invasion and metastasis, providing essential information for clinical tumor diagnosis. Commonly used methods for analysis include fluorescence spectroscopy (FL), photoelectrochemical analysis (PEC), electrochemical analysis (EC), and commercial ELISA kits. Although these methods offer high sensitivity, they can be relatively complex to perform experimentally. Electrochemiluminescence (ECL) has gained widespread research attention due to its high sensitivity, ease of operation, effective spatiotemporal control, and close to zero background signal. RESULTS: In this work, a sandwich-type ECL immunosensor for detecting CD44 was constructed using luminol as a luminophore. In this sensing platform, bimetallic MOFs (Pd@FeNi-MIL-88B) loaded with palladium nanoparticles (Pd NPs) were used as a novel enzyme mimic, exhibiting excellent catalytic performance towards the electroreduction of H2O2. The hybrids provided a strong support platform for luminol and antibodies, significantly enhancing the initial ECL signal of luminol. Subsequently, core-shell Au@MnO2 nanocomposites were synthesised by gold nanoparticles (Au NPs) encapsulated in manganese dioxide (MnO2) thin layers, as labels. In the luminol/H2O2 system, Au@MnO2 exhibited strong light absorption in the broad UV-vis spectrum, similar to the black body effect, and the scavenging effect of Mn2+ on O2•-, which achieved the dual-quenching of ECL signal. Under the optimal experimental conditions, the immunosensor demonstrated a detection range of 0.1 pg mL-1 - 100 ng mL-1, with a detection limit of 0.069 pg mL-1. SIGNIFICANCE: Based on Pd@FeNi-MIL-88B nanoenzymes and Au@MnO2 nanocomposites, a dual-quenching sandwich-type ECL immunosensor for the detection of CD44 was constructed. The proposed immunosensor exhibited excellent reproducibility, stability, selectivity, and sensitivity, and provided a valuable analytical strategy and technical platform for the accurate detection of disease biomarkers, and opened up potential application prospects for early clinical treatment.


Biosensing Techniques , Metal Nanoparticles , Neoplasms , Humans , Manganese Compounds , Gold , Hydrogen Peroxide , Luminol , Reproducibility of Results , Immunoassay , Oxides , Palladium , Hyaluronan Receptors
14.
Anal Chim Acta ; 1303: 342462, 2024 May 15.
Article En | MEDLINE | ID: mdl-38609277

Cortisol, a corticosteroid hormone as a primary stress hormone response to internal and external stress, has been regarded as a gold standard reliable biomarker to evaluate human mental stress. The double enzymes strategy, using nanozyme and enzyme amplifying the electrochemical signal, has been widely used to improve the performance of electrochemical biosensors. An ultra-sensitive electrochemical cortisol sensor based on Au single-atom nanozymes had been fabricated through HRP labeled anti-cortisol antibody binding with Au by Au-S bond. Based on the high catalytic activity of Au single-atom nanozymes and the high selectivity of HRP-labeled anti-cortisol antibodies, the cortisol electrochemical sensor-based Au single-atom nanozymes had an excellent response to cortisol, such as high electrochemical activity, high sensitivity, high selectivity, and wide linear range (0.15-300 ng mL-1) and low detection (0.48 pg mL-1) through the four-parameter logistic model with 95% confidence. The electrochemical cortisol sensor was used to determine the cortisol concentration of human saliva at different times.


Biosensing Techniques , Hydrocortisone , Humans , Immunoassay , Catalysis , Saliva
15.
Eur J Pharmacol ; 973: 176587, 2024 Jun 15.
Article En | MEDLINE | ID: mdl-38642667

Agonist-induced phosphorylation is a crucial step in the activation/deactivation cycle of G protein-coupled receptors (GPCRs), but direct determination of individual phosphorylation events has remained a major challenge. We have recently developed a bead-based immunoassay for the quantitative assessment of agonist-induced GPCR phosphorylation that can be performed entirely in 96-well plates, thus eliminating the need for western blot analysis. In the present study, we adapted this assay to three novel phosphosite-specific antibodies directed against the neurokinin 1 (NK1) receptor, namely pS338/pT339-NK1, pT344/pS347-NK1, and pT356/pT357-NK1. We found that substance P (SP) stimulated concentration-dependent phosphorylation of all three sites, which could be completely blocked in the presence of the NK1 receptor antagonist aprepitant. The other two endogenous ligands of the tachykinin family, neurokinin A (NKA) and neurokinin B (NKB), were also able to induce NK1 receptor phosphorylation, but to a much lesser extent than substance P. Interestingly, substance P promoted phosphorylation of the two distal sites more efficiently than that of the proximal site. The proximal site was identified as a substrate for phosphorylation by protein kinase C. Analysis of GPCR kinase (GRK)-knockout cells revealed that phosphorylation was mediated by all four GRK isoforms to similar extents at the T344/S347 and the T356/T357 cluster. Knockout of all GRKs resulted in abolition of all phosphorylation signals highlighting the importance of these kinases in agonist-mediated receptor phosphorylation. Thus, the 7TM phosphorylation assay technology allows for rapid and detailed analyses of GPCR phosphorylation.


Receptors, Neurokinin-1 , Substance P , Receptors, Neurokinin-1/metabolism , Receptors, Neurokinin-1/agonists , Phosphorylation/drug effects , Humans , Substance P/pharmacology , Animals , Immunoassay/methods , Cricetulus , CHO Cells , Mice , Neurokinin-1 Receptor Antagonists/pharmacology , Neurokinin A/pharmacology , Neurokinin A/metabolism
16.
Biosensors (Basel) ; 14(4)2024 Apr 22.
Article En | MEDLINE | ID: mdl-38667200

Organic electrochemical transistors appear as an alternative for relatively low-cost, easy-to-operate biosensors due to their intrinsic amplification. Herein, we present the fabrication, characterization, and validation of an immuno-detection system based on commercial sensors using gold electrodes where no additional surface treatment is performed on the gate electrode. The steady-state response of these sensors has been studied by analyzing different semiconductor organic channels in order to optimize the biomolecular detection process and its the application to monitoring human IgG levels due to SARS-CoV-2 infections. Detection levels of up to tens of µgmL-1 with sensitivities up to 13.75% [µg/mL]-1, concentration ranges of medical relevance in seroprevalence studies, have been achieved.


Biosensing Techniques , COVID-19 , Electrochemical Techniques , Immunoglobulin G , SARS-CoV-2 , Transistors, Electronic , Humans , Biosensing Techniques/instrumentation , Immunoglobulin G/blood , SARS-CoV-2/immunology , SARS-CoV-2/isolation & purification , COVID-19/diagnosis , COVID-19/blood , Gold/chemistry , Electrodes , Antibodies, Viral , Immunoassay
17.
Anal Chem ; 96(17): 6826-6835, 2024 Apr 30.
Article En | MEDLINE | ID: mdl-38640511

Tumor-marker immunosensors for rapid on-site detection have not yet been developed because of immunoreaction bottlenecks, such as shortening the reaction time and facilitating incubation. In this study, a gold-boron-nitrogen-codoped graphene (Au-BNG)-based immunosensor antenna was constructed for the rapid detection of neuron-specific enolase (NSE). A Au-BNG radiation electrode with dual functions of antibody protein fixation and signal transmission was developed for the first time. A radiation sample cell was constructed by embedding a radiation electrode into the groove of a poly(dimethylsiloxane) dielectric substrate. The constructed sense antenna achieves accurate detection of NSE with a range from 50 fg mL-1 to 40,000 pg mL-1 and a limit of detection of 10.99 fg mL-1, demonstrating excellent selectivity, stability, and reliability. The tumor-marker detection meter can provide NSE detection results as rapidly as within 2 min by using the new strategy of the microwave self-incubation of tumor markers. This antenna immunosensor is suitable for rapid detection in outpatient clinics and can be developed into household tumor-marker detectors, which would be significant in the early detection, long-term monitoring, and efficacy evaluation of tumors.


Biosensing Techniques , Gold , Graphite , Nitrogen , Phosphopyruvate Hydratase , Phosphopyruvate Hydratase/analysis , Graphite/chemistry , Gold/chemistry , Humans , Biosensing Techniques/methods , Nitrogen/chemistry , Immunoassay/methods , Limit of Detection , Biomarkers, Tumor/analysis , Wireless Technology
18.
Biosens Bioelectron ; 257: 116171, 2024 Aug 01.
Article En | MEDLINE | ID: mdl-38636317

The COVID-19 pandemic has highlighted the need for rapid and sensitive detection of SARS-CoV-2. Here, we report an ultrasensitive SARS-CoV-2 immunosensor by integration of an AlGaN/GaN high-electron-mobility transistor (HEMT) and anti-SARS-CoV-2 spike protein antibody. The AlGaN/GaN HEMT immunosensor has demonstrated the capability to detect SARS-CoV-2 spike proteins at an impressively low concentration of 10-22 M. The sensor was also applied to pseudoviruses and SARS-CoV-2 ΔN virions that display the Spike proteins with a single virion particle sensitivity. These features validate the potential of AlGaN/GaN HEMT biosensors for point of care tests targeting SARS-CoV-2. This research not only provides the first HEMT biosensing platform for ultrasensitive and label-free detection of SARS-CoV-2.


Biosensing Techniques , COVID-19 , Gallium , SARS-CoV-2 , Spike Glycoprotein, Coronavirus , Transistors, Electronic , Virion , SARS-CoV-2/isolation & purification , SARS-CoV-2/immunology , Biosensing Techniques/instrumentation , Biosensing Techniques/methods , Spike Glycoprotein, Coronavirus/immunology , Spike Glycoprotein, Coronavirus/analysis , Humans , COVID-19/diagnosis , COVID-19/virology , Gallium/chemistry , Virion/isolation & purification , Virion/chemistry , Limit of Detection , Aluminum Compounds/chemistry , Equipment Design , Immunoassay/instrumentation , Immunoassay/methods , Antibodies, Immobilized/chemistry , Antibodies, Viral
19.
Anal Chem ; 96(18): 7145-7154, 2024 May 07.
Article En | MEDLINE | ID: mdl-38656793

Immunoassays serve as powerful diagnostic tools for early disease screening, process monitoring, and precision treatment. However, the current methods are limited by high costs, prolonged processing times (>2 h), and operational complexities that hinder their widespread application in point-of-care testing. Here, we propose a novel centrifugo-pneumatic reciprocating flowing coupled with spatial confinement strategy, termed PRCM, for ultrafast multiplexed immunoassay of pathogens on a centrifugal microfluidic platform. Each chip consists of four replicated units; each unit allows simultaneous detection of three targets, thereby facilitating high-throughput parallel analysis of multiple targets. The PRCM platform enables sequential execution of critical steps such as solution mixing, reaction, and drainage by coordinating inherent parameters, including motor rotation speed, rotation direction, and acceleration/deceleration. By integrating centrifugal-mediated pneumatic reciprocating flow with spatial confinement strategies, we significantly reduce the duration of immune binding from 30 to 5 min, enabling completion of the entire testing process within 20 min. As proof of concept, we conducted a simultaneous comparative test on- and off-the-microfluidics using 12 negative and positive clinical samples. The outcomes yielded 100% accuracy in detecting the presence or absence of the SARS-CoV-2 virus, thus highlighting the potential of our PRCM system for multiplexed point-of-care immunoassays.


COVID-19 , Centrifugation , SARS-CoV-2 , Immunoassay/methods , Immunoassay/instrumentation , SARS-CoV-2/isolation & purification , Centrifugation/instrumentation , COVID-19/diagnosis , COVID-19/virology , Humans , Microfluidic Analytical Techniques/instrumentation , Lab-On-A-Chip Devices
20.
Anal Chem ; 96(18): 7311-7320, 2024 May 07.
Article En | MEDLINE | ID: mdl-38656817

Human herpesvirus type 6A (HHV-6A) can cause a series of immune and neurological diseases, and the establishment of a sensitive biosensor for the rapid detection of HHV-6A is of great significance for public health and safety. Herein, a bis-tridentate iridium complex (BisLT-Ir-NHC) comprising the N-heterocyclic carbene (NHC) ligand as a novel kind of efficient ECL luminophore has been unprecedently reported. Based on its excellent ECL properties, a new sensitive ECL-based sandwich immunosensor to detect the HHV-6A virus was successfully constructed by encapsulating BisLT-Ir-NHC into silica nanoparticles and embellishing ECL sensing interface with MXene@Au-CS. Notably, the immunosensor illustrated in this work not only had a wide linear range of 102 to 107 cps/µL but also showed outstanding recoveries (98.33-105.11%) in real human serum with an RSD of 0.85-3.56%. Undoubtedly, these results demonstrated the significant potential of the bis-tridentate iridium(III) complex containing an NHC ligand in developing ECL-based sensitive analytical methods for virus detection and exploring novel kinds of efficient iridium-based ECL luminophores in the future.


Coordination Complexes , Electrochemical Techniques , Herpesvirus 6, Human , Iridium , Luminescent Measurements , Methane/analogs & derivatives , Iridium/chemistry , Humans , Immunoassay/methods , Ligands , Coordination Complexes/chemistry , Luminescent Measurements/methods , Electrochemical Techniques/methods , Methane/chemistry , Heterocyclic Compounds/chemistry
...